Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Eslicarbazepine Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 570Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lupin's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
    Lupin's Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    27 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211246

    FDA
    27 Mar 2024
    Share Share
    Hetero's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
    Hetero's Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    03 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211186

    FDA
    03 Aug 2023
    Share Share
    Alkem's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
    Alkem's Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    07 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211199

    FDA
    07 Dec 2022
    Share Share
    Aurobindo's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
    Aurobindo's Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    21 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216481

    FDA
    21 Oct 2022
    Share Share
    Sph Shanghai Zhongxi Pharma's Generic Eslicarbazepine Acetate Receives Approval in US
    Sph Shanghai Zhongxi Pharma's Generic Eslicarbazepine Acetate Receives Approval in US

    22 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211247

    FDA
    22 Sep 2021
    Share Share
    Dr Reddys Labs' Generic Eslicarbazepine Acetate Receives Approval in the U.S
    Dr Reddys Labs' Generic Eslicarbazepine Acetate Receives Approval in the U.S

    29 Jun 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211238

    FDA
    29 Jun 2021
    Share Share